FDA Investigator Douglas C Kovacs

Douglas C Kovacs has conducted inspections on 195 sites in 18 countries as of 05 Dec 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
195
Last Inspection Date:
05 Dec 2022
Investigator Role:
FDA Investigator
Redica ID:
100000754
Countries of Inspections:
United States of America, Hungary, Netherlands, Japan, Czechia, France, Ireland, Italy, Germany, Finland, Argentina, United Kingdom of Great Britain and Northern Ireland, Switzerland, Bulgaria, India, Latvia, Portugal, Canada
FDA Investigators that have inspected at least one site in common with Douglas C Kovacs:
Addam S Reynolds, Ademola O Daramola, Adetutu M Gidado, Alberto A Viciedo, Alicia M Mozzachio, Allen F Hall, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Codella, Amy M Cramer, Amy N Chen, Ana S Cabrera, Anastasia M Shields, Andrew O Ejiofor, Angela E Glenn, Anissa M Vargas, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Antonio M Hampton, Arsen Karapetyan, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Barry Rothman, Bei Yu, Brandi N Mcgrady, Brandy N Lepage, Brenda S Zimmer, PhD, Brett R Havranek, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Brooke K Higgins, Burnell M Henry, Byungja E Marciante, Cara M Minelli, Carl A Anderson, Carl A Huffman, III, Carl A Perez, Cary Greene, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles J Chacko, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Cheryl A Grandinetti, Cheryl Love Harris, Chiang Syin, PhD, Christina Capacci Daniel, PhD, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Christine W Twohy, Christopher R Czajka, Christopher T Middendorf, Concepcion Cruz, Jr, Constance Y Fears, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Daniel B Arrecis, Daniel J Brown, Daniel J Gorski, Daniel J Grabicki, Daniel J Lahar, Daniel J Min, Daniel L Zheng, Darren S Brown, David A Oluwo, David H Smith, David M Beltran, Dawn L Wydner, Deborah A Greco, Deborah B Goffman, Deborah B Nixon, Debra J Bennett, Debra L Pagano, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Deyaa Shaheen, Dinesh Kumar, Don H Bark, PhD, Dorothy J Denes, Douglas A Campbell, Dr. Barbara D Paul, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward D Harris, Edwardstine J Reese, Eileen A Liu, Elizabeth P Mayer, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Erin M Miller, Esteban Beltran, Farhana Khan, Francis A Guidry, Frank J Marciniak, Frank Wackes, Freddy Ortiz Colon, Frederick F Razzaghi, Gavin T Cua, George J Flynn, George M Ibrahim, George Pyramides, Gerald B Seaborn, Jr, Gianine E Delade, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hassan Ali, Helen B Ricalde, Helen Verdel, Herbert M Corbello, Heriberto Negron Rivera, Himanshu Gupta, PhD, Hitesh R Patel, Ifueko Osemwota, Ivis L Negron, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Lane, James C Maclaughlin, James D Hildreth, James R Birkenstamm, Janet A Rajan, Jason M Sluzynski, Javier E Santos, Javier O Vega, Jawaid Hamid, Jay B Shah, Jay T Wong, Jean M Kelahan, Jean M Mulinde, MD, Jeffery B Medwid, PhD, Jeffrey A Sommers, Jeffrey J Ebersole, Jennifer D Hollstrom, Jennifer R Johnson, Jenny Sung, Jessica S Estriplet, Jill M Sooter, Jill Mielziner, Joan A Loreng, Jogy George, John P Mistler, Johnna L Bleem, Joie A Navarrete, Jonathan S Helfgott, Jonee J Mearns, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph R Strelnik, Josh Renzo N Ramilo, Joshua P Wireman, Joy Rkozlowski Klena, Juanita P Versace, Julie D Bringger, Junho Pak, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Karyn M Campbell, Kassa Ayalew, MD, Katherine E Jacobitz, Kathryn E Ogger, Kathy E Craven, Kathy E Noe, Keith M Reilly, Kelley L Clark, Kelli F Dobilas, Kelli F Regenye, Kelli Regente, Kellia N Hicks, Kelly I Anderson, Kenneth H Williams, Kerry A Kurdilla, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kinh Q Mac, Ko U Min, Krishnaiah Yellela, Kristen D Evans, Kristina Nastovski, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Larry Johnson, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Lauren E Burke, Lauren E Sexton, Lauren E Skokan, Lauren L Vajo, Lawrence R Johnson, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Michael H Tollon, Leon L Law, Li Li, Liatte Kreuger, PharmD, Linda Thai, Lisa B Hall, Lisa Harlan, Lisa Mathew, Lisa Shin, Loretta Nemchik, LT Colin E Tack, BSE, Lucas B Leake, Luis A Dasta, Luis Mburgos Medero, Lydia I Rosas Marty, Lynda L Perry, PhD, Manhar R Patel, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret L Bolte, Margaret M Annes, Margaret M Sands, Maria Estrella, Maria Manzoni, PhD, Maria Pkelly Doggett, MBA, Marie B Buen Bigornia, Marjorie D Schultz, Mark E Parmon, Mark G Peterson, Marvin D Jones, Matt D Suedkamp, Matthew A Spataro, Matthew B Casale, Mayar M Mussa, Megan A Haggerty, Meisha Waters, Melba Trivera Clavell, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meredith P Soehl, Investigator, Merril E Racke, Meyer J Slobotsky, Michael A Charles, Michael D Omeara, Michael E Maselli, Michael J Verdi, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele L Forster, PhD, Michele Perry Williams, Miguel A Martinez Perez, Mihaly S Ligmond, Milva E Melendez Perales, Minh D Phan, Misty D Harvey, Mobin A Tawakkul, Monica M Mcclure, Monika Borkowska, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Mra V Millarw, Nadeem I Chaudhry, Nancy F Scheraga, Nancy G Schmidt, Nancy L Rolli, Nancy M Espinal, Neal L Adams, Nelson A Rodriguez, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Nicole A Lloyd, Nicole E Knowlton, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj R Mehta, PhD, Omotunde O Osunsanmi, Paige R Mccoy, Parul M Patel, Patrice S Hall, Patricia D Stahnke, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Peter C Chow, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Puspa Suresh Jayasekara, Qin Xu, Rachael A Moliver, Ralph H Vocque, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Regina T Brown, Richard D Manney, Richard E Needham, Richard H Penta, Richard Jay Tucker, RS, Richard Ledwidge (nmi), PhD, Richard W Thornton, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert Jennings, Robert M Barbosa, Robert Sharpnack, Robin P Mathew, Rochelle K Kimmel, Rochelle L Campbell, Rochelle L Cross, Rodney G Raiford, Rodney T Allnutt, Rodrigo Vilchez, Rose Ljean Mary, Roy Baby, Russell J Glapion, Russell K Riley, Sachinkumar V Patel, Saleem A Akhtar, Samir C Gala, Sandra A Boyd, Sandra A Hughes, Sandra Kershaw, Santos E Camara, Sarah Adella Fave, Sarah E Mcmullen, Satheesh K Podaralla, Satheesh Thomas, Schultz, Scott T Ballard, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Shawn E Larson, Sherri J Liu, Sherry G Bous, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Simone E Pitts, Sinai I Davis, Sneha S Patel, Sonia R Peterson, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Steven A Gonzales, Steven C Madzo, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Suchan Kim, Sunita Iyer, Susan M Halsted, Susan M Jackson, Susan T Hadman, Susanna E Ford, Taichun Qin, PhD, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Tekalign Wondimu, Temar Q Williams, Teresa I Navas, Terri L Dodds, Theodore N Sietsema, Thomas J Arista, Tonia F Bernard, Tonya R Johnson, Torrance J Slayton, Towanda L Terrell, Toyin B Oladimeji, Travis S Bradley, Tressa T Lewis, Tyanna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie C Reed, Valerie L Whipp, Valerie Reed, Vera M Anderson, Veronica Fuentes, MS, Victoria Spivak, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Wayne J Meyer, Wei Wang, PhD, Wendy G Tan, PhD, William J Muszynski, William R Chang, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Xiuju Lu, Yangmin Ning, Yasamin Ameri, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Zachary L Miller, Zakaria I Ganiyu, Zhijin Chen

Douglas C Kovacs's Documents

Publish Date Document Type Title
March, 2001 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2001-03-23
August, 2003 EIR Actavis Totowa LLC - EIR, 2003-08-21
January, 2003 FDA 483 Actavis Elizabeth LLC - Form 483, 2003-01-15
June, 2003 FDA 483 Response Unigene Laboratories, Inc. - Form 483R, 2003-06-27
October, 2003 FDA 483 Response Halo Pharmaceuticals Inc. - Form 483R, 2003-11-05
April, 2003 FDA 483 Response Penick Corp - Form 483R, 2003-04-10
December, 2007 FDA 483 Ranbaxy, Inc. - Form 483, 2007-12-19
February, 2008 EIR Hoffmann La Roche Inc - EIR, 2008-02-05
October, 2003 EIR Halo Pharmaceuticals Inc. - EIR, 2003-10-24
September, 2009 FDA 483 EMSL Analytical, Inc. DBA MPL Laboratories - Form 483, 2009-09-18
June, 2013 EIR LEADING PHARMA, LLC - EIR, 2013-06-12
September, 2001 FDA 483 Response The P.F. Laboratories Inc. - Form 483R, 2001-09-26
December, 2005 FDA 483 Merck, Inc. - Form 483, 2005-12-14
June, 2003 FDA 483 Unigene Laboratories, Inc. - Form 483, 2003-06-16
April, 2003 EIR Penick Corp - EIR, 2003-04-03
February, 2000 EIR Frutarom USA Inc. - EIR, 2000-02-16
January, 2023 FDA 483 Jamol Laboratories, Inc. - Form 483, 2023-01-12
September, 2005 FDA 483 Eli Lilly And Co. Limited - Form 483, 2005-09-15
December, 2000 FDA 483 Reed-Lane, Inc. - Form 483, 2000-12-15
February, 2020 EIR SOLARA ACTIVE PHARMA SCIENCES LIMITED - EIR, 2020-02-21
March, 2000 FDA 483 I S P Van Dyk Inc - Form 483, 2000-03-09
August, 2003 FDA 483 Actavis Totowa LLC - Form 483, 2003-08-21
June, 2001 EIR Fermion Oy - EIR, 2001-06-21
November, 2001 EIR Ivax Pharmaceuticals Inc - EIR, 2001-11-29
October, 2003 FDA 483 Contract Coating Inc. - Form 483, 2003-10-10
August, 2012 EIR Novartis Pharmaceuticals Corporation - EIR, 2012-08-23
November, 2001 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2001-11-29
July, 2004 FDA 483 Response Mead Johnson & Company, LLC - Form 483R, 2004-08-05
August, 2013 FDA 483 Response ImprimisRx NJ - Form 483R, 2013-09-03
September, 2001 EIR The P.F. Laboratories Inc. - EIR, 2001-09-21
November, 2000 FDA 483 Novus Fine Chemicals - Form 483, 2000-11-27
September, 2001 FDA 483 The P.F. Laboratories Inc. - Form 483, 2001-09-21
September, 2010 EIR Novartis Pharmaceuticals Corporation - EIR, 2010-09-03
November, 2000 EIR McNeil PPC Inc. - EIR, 2000-11-08
May, 2001 EIR SGS North America Inc. - EIR, 2001-05-23
June, 2002 FDA 483 Response Ivax Pharmaceuticals Inc - Form 483R, 2002-07-10
October, 2003 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2003-10-24
October, 2003 EIR Contract Coating Inc. - EIR, 2003-10-10
June, 2004 FDA 483 Response Pliva, Inc. - Form 483R, 2004-06-16
August, 2006 FDA 483 Elite Laboratories, Inc. - Form 483, 2006-08-04
August, 2011 FDA 483 Englewood Lab, Inc. - Form 483, 2011-08-25
September, 2003 FDA 483 Ingenus Pharmaceuticals NJ LLC - Form 483, 2003-09-19
June, 2000 FDA 483 Knoll Pharmaceutical Company - Form 483, 2000-06-20
February, 2011 FDA 483 Hoffmann La Roche Inc - Form 483, 2011-02-04
June, 2002 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2002-06-20
November, 2000 FDA 483 Response Novus Fine Chemicals - Form 483R, 2000-12-01
July, 2009 FDA 483 Ingenus Pharmaceuticals NJ LLC - Form 483, 2009-07-07
November, 2000 EIR Novus Fine Chemicals - EIR, 2000-11-27
January, 2005 EIR Aphena Pharma Solutions - EIR, 2005-01-25
May, 2007 FDA 483 Response Central Admixture Pharmacy Services, Inc. - Form 483R, 2007-06-15
November, 2008 FDA 483 DERMARITE INDUSTRIES, LLC - Form 483, 2008-11-17
September, 2003 EIR Ingenus Pharmaceuticals NJ LLC - EIR, 2003-09-19
October, 2007 FDA 483 LEADING PHARMA, LLC - Form 483, 2007-10-23
April, 2003 EIR Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - EIR, 2003-04-24
June, 2000 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2000-06-20
July, 2002 EIR Pliva, Inc. - EIR, 2002-07-26
July, 2003 EIR MERCK SERONO SPA - EIR, 2003-07-21
May, 2001 FDA 483 Response SGS North America Inc. - Form 483R, 2001-06-15
July, 2003 FDA 483 MERCK SERONO SPA - Form 483, 2003-07-21
January, 2003 EIR Actavis Elizabeth LLC - EIR, 2003-01-15
October, 2002 EIR DMV International - EIR, 2002-10-17
May, 2018 FDA 483 HOVIONE FARMACIÊNCIA, S.A. - Form 483, 2018-05-18
December, 2007 EIR Ranbaxy, Inc. - EIR, 2007-12-19
April, 2000 FDA 483 Response TEVA Pharmaceuticals USA Inc - Form 483R, 2000-05-10
December, 2003 FDA 483 Response Lilly France - Form 483R, 2004-02-18
April, 2000 FDA 483 TEVA Pharmaceuticals USA Inc - Form 483, 2000-04-26
May, 2018 EIR HOVIONE FARMACIÊNCIA, S.A. - EIR, 2018-05-18
May, 2003 EIR Baxter Healthcare Corporation - EIR, 2003-05-12
May, 2007 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2007-05-08
July, 2007 EIR Amneal Pharmaceuticals, LLC - EIR, 2007-07-17
August, 2000 FDA 483 Response Halo Pharmaceuticals Inc. - Form 483R, 2000-08-29
December, 2010 FDA 483 Unipack LLC - Form 483, 2010-12-08
August, 2009 FDA 483 Hoffmann La Roche Inc - Form 483, 2009-08-18
April, 2000 EIR TEVA Pharmaceuticals USA Inc - EIR, 2000-04-26
July, 2007 FDA 483 Response Amneal Pharmaceuticals, LLC - Form 483R, 2007-08-07
October, 2001 FDA 483 Response Watson Pharma, Inc. - Form 483R, 2001-12-03
April, 2004 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2004-04-15
February, 2013 FDA 483 Actavis Elizabeth LLC - Form 483, 2013-02-15
July, 2004 FDA 483 Mead Johnson & Company, LLC - Form 483, 2004-07-23
March, 2001 FDA 483 Actavis Elizabeth LLC - Form 483, 2001-03-12
May, 2001 FDA 483 SGS North America Inc. - Form 483, 2001-05-23
September, 2005 EIR Eli Lilly And Co. Limited - EIR, 2005-09-15
August, 2013 FDA 483 Novel Laboratories, Inc. - Form 483, 2013-09-11
August, 2000 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2000-08-04
June, 2000 FDA 483 Response Halo Pharmaceuticals Inc. - Form 483R, 2000-07-13
July, 2003 FDA 483 NPBI International BV - Form 483, 2003-07-11
February, 2013 EIR Actavis Elizabeth LLC - EIR, 2013-02-15
May, 2008 FDA 483 Actavis Elizabeth LLC - Form 483, 2008-05-21
June, 2000 EIR Knoll Pharmaceutical Company - EIR, 2000-06-13
November, 2022 EIR CAMBREX PROFARMACO MILANO SRL - EIR, 2022-12-22
June, 2000 EIR Halo Pharmaceuticals Inc. - EIR, 2000-06-20
August, 2013 FDA 483 ImprimisRx NJ - Form 483, 2013-08-19
December, 2003 EIR Lilly France - EIR, 2003-12-08
May, 2009 FDA 483 Pliva, Inc. - Form 483, 2009-05-05
June, 2012 FDA 483 AustarPharma LLC - Form 483, 2012-06-05
March, 2009 FDA 483 Actavis Totowa LLC - Form 483, 2009-03-31
February, 2000 EIR McNeil PPC Inc. - EIR, 2000-02-09
July, 2004 EIR Mead Johnson & Company, LLC - EIR, 2004-07-23
April, 2003 FDA 483 Penick Corp - Form 483, 2003-04-03
October, 2001 FDA 483 Watson Pharma, Inc. - Form 483, 2001-10-30
July, 2008 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2008-07-29
March, 2008 EIR Discovery Laboratories Inc. - EIR, 2008-03-25
September, 2002 EIR Barr Laboratories, Inc. - EIR, 2002-09-06
December, 2000 FDA 483 Response Reed-Lane, Inc. - Form 483R, 2000-12-21
June, 2002 EIR Ivax Pharmaceuticals Inc - EIR, 2002-06-20
October, 2002 FDA 483 Response DMV International - Form 483R, 2002-10-31
February, 2013 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2013-03-08
March, 2003 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2003-03-07
March, 2012 EIR Teva Pharmaceuticals USA, Inc. - EIR, 2012-03-30
April, 2004 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2004-04-15
October, 2002 FDA 483 DMV International - Form 483, 2002-10-17
June, 2004 FDA 483 Pliva, Inc. - Form 483, 2004-06-02
July, 2003 FDA 483 Response MERCK SERONO SPA - Form 483R, 2003-08-01
June, 2011 FDA 483 Genzyme Corporation - Form 483, 2011-06-21
June, 2013 FDA 483 LEADING PHARMA, LLC - Form 483, 2013-06-12
May, 2005 FDA 483 Hoffmann La Roche Inc - Form 483, 2005-05-27
May, 2005 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2005-06-28
August, 2010 FDA 483 Contract Coating Inc. - Form 483, 2010-08-02
July, 2013 EIR JAK Diversified II, Inc. dba Multi-Pak Packaging - EIR, 2013-07-22
May, 2005 EIR Hoffmann La Roche Inc - EIR, 2005-05-27
September, 2019 EIR DSM Nutritional Products AG Zweigniederlassung Werk Sisseln - EIR, 2024-01-18
March, 2003 EIR Ivax Pharmaceuticals Inc - EIR, 2003-03-07
March, 2001 EIR Actavis Elizabeth LLC - EIR, 2001-03-12
July, 2007 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2007-07-17
January, 2002 EIR Merck Sharp & Dohme LLC - EIR, 2002-01-28
December, 2000 EIR Reed-Lane, Inc. - EIR, 2000-12-15
August, 2003 FDA 483 Response Actavis Totowa LLC - Form 483R, 2003-09-19
September, 2002 EIR Ivax Pharmaceuticals Inc - EIR, 2002-09-19
January, 2002 EIR Abbott Laboratories - EIR, 2002-01-11
October, 2003 FDA 483 Response Contract Coating Inc. - Form 483R, 2004-01-02
February, 2008 FDA 483 Hoffmann La Roche Inc - Form 483, 2008-02-05
March, 2000 EIR I S P Van Dyk Inc - EIR, 2000-03-09
June, 2000 FDA 483 Response Knoll Pharmaceutical Company - Form 483R, 2000-06-23
June, 2004 EIR Pliva, Inc. - EIR, 2004-06-02
June, 2003 EIR Unigene Laboratories, Inc. - EIR, 2003-06-16
February, 2000 EIR Novartis Pharmaceuticals Corporation - EIR, 2000-12-21
April, 2003 FDA 483 Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - Form 483, 2003-04-24
February, 2003 EIR Sharp Corporation - EIR, 2003-02-21
August, 2000 EIR Halo Pharmaceuticals Inc. - EIR, 2000-08-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more